Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Isotretinoin was not effective in treating facial lichen planopilaris.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

The woman's skin and hair symptoms were confirmed as frontal fibrosing alopecia, and while facial papules are common in such cases, there's no effective local treatment, but systemic treatments can help.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

A rare case of a woman having both lichen planus pigmentosus and classic lichen planopilaris at the same time.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

The document focused on hair disorders, especially alopecia, and discussed treatments and impacts on quality of life.

The document discusses various nail and hair disorders and their treatments.

Oral Minoxidil effectively treats hair loss with increased hair growth as a side effect, and low doses are generally safe.

A rare skin condition affected only the facial hair of a 46-year-old man.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

MicroRNAs may help diagnose and treat hair loss disorders.

The review found that women using hair loss drugs like finasteride and dutasteride rarely reported sexual side effects.

A woman developed swelling in her body after taking low-dose oral minoxidil for hair loss, but it resolved after stopping the medication.

IL-23 inhibitors may help treat other skin conditions, but more research is needed.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Patients with skin disorders face higher risks of complications in facial cosmetic surgery.

Lichen Planus in siblings may be influenced by genetics and environment.

Accurate diagnosis and personalized treatment are crucial in dermatopathology.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

The document concludes that there have been significant advances in the treatment and diagnosis of various skin conditions.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

Gabapentin may help relieve itchy scalp in lichen planopilaris patients.